More Commerce, Less Data?

The emergence of biology-based commercial enterprises is not only fostering difficulties between the private and public sectors regarding access to research resources; it may even affect the way basic science is conducted. A letter report issued recently by the National Research Council (NRC) identifies the most pressing issues of this multifaceted problem and recommends how to begin solving it. The report, by a 26-member life sciences commission, derives from an NRC conference held in early 199

Written bySteve Bunk
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The emergence of biology-based commercial enterprises is not only fostering difficulties between the private and public sectors regarding access to research resources; it may even affect the way basic science is conducted. A letter report issued recently by the National Research Council (NRC) identifies the most pressing issues of this multifaceted problem and recommends how to begin solving it. The report, by a 26-member life sciences commission, derives from an NRC conference held in early 1999 and subsequent discussions.

Commission member David V. Galas, chief academic officer at Keck Graduate Institute, observes, "In some ways, now that biology has become an important financial force, it's natural that this should happen." Noting that chemistry and electrical engineering have already extended from basic science into commercial enterprise, he says that lessons learned from them, though helpful, may not be fully transferable to biology. "I think even in a very strongly market-driven economy, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies